BSX - Boston Scientific Corp

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

52W High

$108.94

52W Low

$80.64

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

0.66

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

63.82

Forward P/E (<15 better)

31.55

EV/EBITDA (<8 favorable)

36.67

EV/Revenue (<3 favorable)

9.21

P/S (TTM) (<3 favorable)

8.59

P/B (<3 favorable)

7.09

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.19%

Institutions (25–75% balanced)

93.63%

Shares Outstanding

1,481,750,000

Float

1,477,469,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

18,493,999,000

Gross Profit (TTM)

12,583,999,000

EPS (TTM)

1.68

Profit Margin (>10% good)

0.14%

Operating Margin (TTM) (higher better)

0.19%

ROE (TTM) (>15% strong)

0.12%

EPS YoY (Quarterly) (>10% good)

1.41

Revenue YoY (Quarterly) (>8% good)

0.23

Momentum

Bearish momentum

Value

0.1416

0.5601

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025